Yuxiang Ma (Li Zhang)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Epidermal Growth Factor Receptor

Chronic Myeloid Leukemia

Ejection Fraction

Top Venues

NPJ precision oncology

Drug design, development and therapy

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Yuxiang Ma, Hua-Qiang Zhou, Fan Luo, Yang Zhang, Changbin Zhu, Weiwei Li, Zhan Huang, Jingbo Zhao, Jinhui Xue, Yuanyuan Zhao, Wenfeng Fang, Yunpeng Yang, Yan Huang, Li Zhang, Hongyun Zhao
Remodeling the tumor-immune microenvironment by anti-CTLA4 blockade enhanced subsequent anti-PD-1 efficacy in advanced nasopharyngeal carcinoma. NPJ precision oncology 8 (1) (2024)
Jinhui Xue, Haipeng He, Zuan Lin, Yuehan Wu, Yuehao Lin, Hongyun Zhao, Salvatore J Salamone, Yan Huang, Yunpeng Yang, Wenfeng Fang, Yang Zhang, Shaodong Hong, Yuxiang Ma, Yuxiang Ma
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studies. Cancer chemotherapy and pharmacology 90 (3) (2022)
Jixian Liu, Zhimin Mu, Li Liu, Kang Li, Richeng Jiang, Peng Chen, Qiang Zhou, Meiling Jin, Yuxiang Ma, Yuancai Xie, Jianxing Xiang, Bing Li, Yafeng Ma, Xinru Mao, Lu Zhang, Tengfei Zhang, Da Wu
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients. Drug design, development and therapy 13 (2019)